If confirmed, the safety review could herald the imposition of restrictions on the use of the antibodies by HHS, which has ...

Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...

The move into the UK weight-loss category has been facilitated by the acquisition earlier this year of Zava, a London-based ...

CB1 inhibition is an approach that taps into the body’s natural metabolism to burn fat while preserving muscle for more ...

The first CNPV approval falls into the latter category, and is for a US-manufactured version of the widely used antibiotic ...

The UK government has confirmed that the rebate rate for newer medicines supplied to the NHS under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5% next year, ...

Technology maturity: Technology has reached a level of maturity that allows integration of various systems and devices to be seamless. Connected health devices and cloud platforms have evolved from ...

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

Relation's draw is its 'lab-in-a-loop' process of AI-driven target and drug discovery, in which algorithms are used to find ...

The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...

The reversible BTK inhibitor was at least as effective as AbbVie/Johnson & Johnson's older, non-reversible drug Imbruvica ...